Biphenyl-2-ylcarbamicacid1- (2-{[4- (4-carbamoylpiperidin-1-ylmethyl) benzoyl] methylamino} ethyl) piperidin-4-ylester CAS 864750-70-9

Khoom Piav Qhia:

Khoom Lub Npe:

biphenyl-2-ylcarbamicacid1- (2-{[4- (4-carbamoylpiperidin-1-ylmethyl) benzoyl] methylamino} ethyl) piperidin-4-ylester CAS TSIS TAU: 864750-70-9

Lub ntsiab lus:

1- (2- (3-((4-carbamoylpiperidin-1-yl) methyl) -N-methylbenzamido) ethyl) piperidin-4-yl [1,1' -biphenyl] -2-ylcarbamate;

Revefenacin: TD-4208: GSK-1160724;

TD-4208;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Crystalline khoom

Kev Ntsuas: ≥98.0%

Ceev: 1.26 ± 0.1 g/cm3 (Kwv yees)

Melting Point: 125 ℃

Kub Point: 777.5 ± 60.0 ℃ (Kwv yees)

PKa: 13.34 ± 0.70 (kwv yees)

Flash Point: 424.0 ± 32.9 ℃

Vapor Siab: 0.0 ± 2.7 mmHg ntawm 25 ℃

Index ntawm Refraction: 1.645

Revefenacin yog cov txheej txheem tshiab, tsis xaiv, ua kom ntev muscarinic alkaline antagonist uas thaiv M3 receptors hauv cov leeg ua pa. Kev thaiv ntawm cov neeg txais khoom no tiv thaiv acetylcholine - ua rau cov hlab ntsws txhaws, yog li ua rau lub ntsws so. Cov kev tsis zoo tshwm sim (1%-10%) hauv kev kuaj mob yog mob taub hau, nasopharyngitis, mob ua pa rau sab hauv, mob nraub qaum, mob ntsws, kiv taub hau, kub siab, thiab lwm yam.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: biphenyl-2-ylcarbamicacid1- (2-{[4- (4-carbamoylpiperidin-1-ylmethyl) benzoyl] methylamino} ethyl) piperidin-4-ylester cas 864750-70-9, cov chaw tsim khoom, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: PQR530 CAS 1927857-61-1
• Tom ntej: AZD9496 CAS 1639042-08-2